Granzyme B Monoclonal Antibody

Granzyme B Monoclonal Antibody

CAT N°: 37067
Price:

From 168.00 142.80

Granzyme B is a serine protease that is involved in cytotoxic T lymphocyte- and natural killer cell-induced cell death.{58841,58846} It localizes to cytoplasmic granules prior to release into the immunological synapse formed with a target cell.{58847,58841} Granzyme B cleaves its substrates after an aspartate residue and targets caspase-3, caspase-8, and gasdermin E (GSDME), among others.{58841,58846} It is involved in caspase-dependent and -independent apoptosis, necrosis, DNA fragmentation, pyroptosis, viral infection, and antitumor immunity.{58841,58846,58848} Knockout of the gene encoding granzyme B, GZMB, reduces disease severity in a mouse model of epidermolysis bullosa acquisita, an autoimmune disease characterized by blistering of the skin.{58849} Serum and synovial levels of granzyme B are elevated in patients with rheumatoid arthritis.{58850} Cayman’s Granzyme B Monoclonal Antibody can be used for ELISA and immunohistochemistry (IHC) applications.

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View